Menu Search
Equities

Stayble Therapeutics AB

4K4:STU

Stayble Therapeutics AB

Actions
  • Price (EUR)0.0463
  • Today's Change-0.003 / -6.09%
  • Shares traded0.00
  • 1 Year change-87.38%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2023, Stayble Therapeutics AB increased its cash reserves by 9.60%, or 1.23m. Cash Flow from Financing totalled 24.96m or -- of revenues. In addition the company used 23.54m for operations while cash from investing was breakeven.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.2795
Tangible book value per share0.1503
More ▼

Balance sheet in SEKView more

Stayble Therapeutics AB appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 14.08m. In fact, 0.49% of the value of Stayble Therapeutics AB shares can be attributed to this cash.
Current ratio3.74
Quick ratio--
Total debt/total equity0.0696
Total debt/total capital0.065
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.